Implementing a novel multimode 3D retinal imaging system to investigate metabolism and vascular disruptions in diabetic retinopathy
Implementing a novel multimode 3D retinal imaging system to investigate metabolism and vascular disruptions in diabetic retinopathy
批准号:
10349947
负责人:
Mahsa Ranji
金额:
$34.62万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2024-05-31
中文摘要
糖尿病导致视网膜微血管和细胞氧化还原并发症以及糖尿病的发展
视网膜病变(DR)。糖尿病对视网膜神经血管功能产生不利影响的早期机制
完整性和糖尿病视网膜病变进展,人们对此知之甚少。这种缺乏理解的情况受到了阻碍
由于无法及早和非侵入性地检测和研究这些变化。有迫切的需要
非侵入性成像工具和定量生物标志物作为糖尿病对视网膜不良影响的指标
神经血管、新陈代谢和功能。这项研究的主要前提是解决
现有的工具可以同时和无创地测量线粒体氧化还原状态和视网膜神经血管
糖尿病期间的正直。这些测量将提供生物标记物,可用于初级保健
设置。
这一领域项目的主要假设是糖尿病刺激线粒体功能障碍,
OXS增加,以及视网膜中可以非侵入性检测到的神经血管破坏。我们的团队会
实施MM-cSLO以评估糖尿病Akita/+小鼠这些变化,以测试早期对
线粒体氧化还原状态和神经血管完整性在视网膜功能障碍中至关重要。有三个具体的
旨在验证这些假设1)设计并实现了一种多模共焦扫描激光检眼镜
(mm-cSLO)用于DR生物标志物的高分辨率时空成像。2)确定视网膜的变化
糖尿病时的血管网络、氧合和线粒体功能障碍。
这些研究的结果将确定线粒体功能障碍和神经血管的过程
糖尿病早期诊断中断的变化。这种非侵入性成像方式的使用可以允许
基于个体化风险与收益评估的糖尿病患者的检测和治疗
实时的。来自视网膜成像的解剖和功能信息的相关性可以帮助阐明
视网膜成像结果的功能结果,并为将其用作结果提供进一步支持
治疗干预措施。如果这些检测和治疗方法被证明是有效的,它们可能
在翻译研究中立即得到评估。
这一领域的应用将为培养UWM提供一个独特的跨学科教育平台
本科生和研究生。对于学生来说,有非常广泛和非常丰富的教育机会。
学习电子学、光学、仪器仪表、生物学、生物化学、计算机编程
只有在这种跨学科的方法下才能完成的具体研究项目。这样的一种
教育平台将增加UWM电气专业本科生的参与度
工程学和生物医学工程学的研究。这些研究活动的成功实施将
促进长期、可持续的目标,即从工作台到临床床边的转变。
英文摘要
Diabetes causes microvascular and cellular redox complications in the retina and development of diabetic
retinopathy (DR). The early mechanisms by which diabetes adversely affects retinal neurovascular function and
integrity, and diabetic retinopathy progression, are poorly understood. This lack of understanding is hampered
by the inability to detect and study these changes early and non-invasively. There is a crucial need for
noninvasive imaging tools and quantitative biomarkers as indicators of diabetes’ adverse effect on the retinal
neurovasculature, metabolism, and function. The main premise of this study is addressing the significant gap in
existing tools to simultaneously and noninvasively measure mitochondrial redox state, and retinal neurovascular
integrity during diabetes. These measurements will provide biomarkers, which could be used in primary care
settings.
The main hypothesis of this AREA project is that diabetes stimulates mitochondrial dysfunction,
increased OxS, and neurovascular disruption in the retina that can be detected non-invasively. Our team will
implement a MM- cSLO to evaluate these changes in diabetic Akita/+ mice to test that early disruption of
mitochondrial redox states and neurovascular integrity is critical in retinal dysfunction. There are three specific
aims to test these hypotheses.1) Design and implement a multimodal confocal scanning laser ophthalmoscope
(MM-cSLO) for high resolution spatiotemporal imaging of DR biomarkers. 2) Determine changes in the retinal
vascular network, oxygenation, and mitochondrial dysfunction during diabetes.
The outcome of these studies will establish the course of mitochondrial dysfunction and neurovascular
disruption in early diagnosis of diabetes changes. The use of this non-invasive imaging modality could permit
detection and treatment of patients with diabetes based upon individualized risk versus benefit assessments in
real time. Correlation of anatomical and functional information from retinal imaging could help elucidate the
functional consequences of the findings of retinal imaging and provide further support for their use as outcomes
measures of therapeutic intervention. If these detection and treatment methods are proven effective, they could
be immediately evaluated in translational research.
This AREA application will lead to a unique interdisciplinary educational platform for training UWM
undergraduate and graduate students. There is a very broad and very rich educational opportunity for students
to learn about electronics, optics, instrumentation, biology, biochemistry, computer programing wrapped in
specific research project that can only be accomplished in such an interdisciplinary approach. Such an
educational platform would increase the participation of UWM’s undergraduates majoring in electrical
engineering and biomedical engineering in research. Successful implementation of these research activities will
facilitate the long term, sustainable goal of translation from bench side to clinical bedside.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: